Cognyte Software Q1 2027 Revenue Jumps 18% on New Analytics Suite
0h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
cognyte-softwareearnings-preview
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Cognyte Software Ltd. is projected to report a significant year-over-year revenue increase of 18% for its first quarter of fiscal year 2027, according to a preview of the upcoming earnings report. The company is expected to announce revenue of $112 million, with non-GAAP earnings per share of $0.08. Data from the preview indicates that gross margins expanded to 73.2%, up 220 basis points from the prior-year quarter. The company is set to release these results on Wednesday, June 9, 2026, after market close.
The revenue growth trajectory marks a departure from Cognyte's recent historical performance. The company reported a year-over-year revenue decline of 4.5% in Q1 2026, making the projected 18% gain a sharp reversal. This shift coincides with the global enterprise cybersecurity analytics market growing at a 15.2% CAGR, accelerating demand for advanced threat intelligence solutions.
Current macro conditions are favorable for cybersecurity spending despite broader tech sector pressures. The NASDAQ Composite is up 6.2% year-to-date, while the iShares Cybersecurity and Tech ETF (IHAK) has gained 9.1%. Persistent geopolitical tensions and a high-profile corporate espionage case in April 2026 have kept security budgets insulated from cuts.
The immediate catalyst for Cognyte's performance is the successful launch of its Argus Analytics Suite in Q4 2026. The suite integrates artificial intelligence for predictive threat modeling, a capability that directly addresses mandates from new EU data sovereignty regulations enacted in March 2026.
Key financial metrics for Cognyte's Q1 2027, compared to Q1 2026, show the scale of the expected improvement. Revenue is projected at $112.0 million versus $94.9 million, an 18.0% increase. Non-GAAP gross margin is forecast at 73.2%, up from 71.0%. Non-GAAP operating income is expected to be $8.5 million, representing a 7.6% margin, a substantial recovery from the $1.2 million loss reported a year ago.
The company's projected performance outpaces its direct public peer, Cellebrite DI Ltd., which analysts expect to report 12% revenue growth for its concurrent quarter. Cognyte's free cash flow is also anticipated to turn positive, reaching an estimated $5.1 million. This improvement is linked to the Argus Suite, which carries an average contract value 35% higher than legacy product lines.
Cognyte's results signal a reinvigoration in the niche investigative analytics software sector, which had faced margin compression. A strong report would likely benefit related tickers like Cellebrite (CLBT) and Palantir Technologies (PLTR), which operates in adjacent data analytics markets. Analyst consensus suggests a 3-5% positive sympathy move for these peers if Cognyte's numbers meet or exceed expectations.
The primary risk to this thesis is customer concentration. Approximately 22% of Cognyte's revenue still comes from government contracts, which are subject to budgetary delays. A counter-argument exists that the initial Argus Suite deals represent a pull-forward of demand that may not be sustained into Q2.
Positioning data from options markets shows an unusually high put-to-call ratio of 1.8 for Cognyte ahead of earnings, indicating skepticism among some traders. However, institutional ownership has increased by 4.7 percentage points over the last quarter, suggesting larger funds are establishing long positions ahead of the report.
The immediate catalyst is the earnings call on June 9, 2026. Management's commentary on annual recurring revenue for the Argus Suite and full-year guidance will be critical. The next major catalyst is the Echelon Cybersecurity Conference in Tel Aviv on July 15-16, where Cognyte is slated to give a keynote on its AI roadmap.
Key technical levels for the stock post-earnings are $7.80 as support, representing the 200-day moving average, and $9.40 as resistance, the 52-week high set in November 2025. A sustained break above $9.40 on high volume would confirm the new growth narrative.
Investors should monitor the US Department of Homeland Security's upcoming procurement announcement for analytics tools, expected by August 1, 2026. Cognyte is a qualified bidder, and a win would provide tangible validation of its technology shift.
Cognyte Software provides investigative analytics solutions, primarily for government and enterprise security teams. Its software analyzes massive datasets from communications, financial transactions, and digital networks to uncover hidden threats and patterns. The newly launched Argus Analytics Suite uses machine learning to predict security incidents before they occur, moving the company from reactive reporting to proactive intelligence.
An 18% year-over-year revenue growth rate is highly significant for Cognyte, representing its fastest growth pace in over three years. For context, the company's average revenue growth over the previous eight quarters was 2.1%. This acceleration suggests the new product cycle is gaining material traction and could support a re-rating of the stock if sustained.
Cognyte operates in a specialized niche distinct from endpoint security leaders like CrowdStrike. While CrowdStrike focuses on preventing breaches on devices, Cognyte's software is used after a suspicion is raised, to investigate complex crimes, fraud, or espionage. Its closest public competitors are Cellebrite, which specializes in mobile device forensics, and certain modules of Palantir's Gotham platform used by defense agencies.
Cognyte's projected 18% revenue surge signals a decisive product-led turnaround in the high-margin investigative analytics market.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Position yourself for the macro moves discussed above
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.